The International Type 1 Diabetes Summit 2026 takes place in Jodhpur, Rajasthan, from 30 July to 1 August 2026 and is organised by The Friends of Mewar, Breakthrough T1D and the William J. Clinton Foundation.
Summit details
- Dates & venue: Jodhpur, Rajasthan; 30 July–1 August 2026.
- Organisers: The Friends of Mewar; Breakthrough T1D; William J. Clinton Foundation.
- Participants: Endocrinologists, researchers, policymakers and patient advocates from India, the United States and Australia.
Type 1 diabetes — clinical profile
- Pathophysiology: Autoimmune destruction of pancreatic beta cells causing absolute insulin deficiency.
- Diagnostic markers: Low C‑peptide and diabetes autoantibodies (GAD65, IA‑2, ZnT8) aid differentiation from other types.
- Age of onset: Commonly childhood/adolescence but may present at any age.
Summit themes & technology
- Policy and access: Insulin access and equitable Type 1 care within national health frameworks.
- Mental health: Psychosocial support and structured care models for chronic disease burden.
- Diabetes technology: Continuous glucose monitoring (CGM), insulin pumps and hybrid closed‑loop (automated insulin delivery) systems.
- Digital health: Remote glucose monitoring, telemedicine and data‑driven decision support tools.
IASPOINT Booster Facts
- Insulin history: First used clinically in 1922.
- Essential medicine: Insulin is listed on the WHO Model List of Essential Medicines.
- Autoimmunity classification: Type 1 is an autoimmune endocrine disorder managed within endocrinology.
- Technology terms: CGM measures interstitial glucose; hybrid closed‑loop links CGM with an insulin pump via an algorithm.